May 2, 2013 / 10:20 AM / in 4 years

Valeant posts bigger loss as costs rise

May 2 (Reuters) - Valeant Pharmaceuticals International Inc , Canada’s biggest publicly traded drugmaker, reported a bigger first-quarter loss as expenses rose due to its $2.6 billion acquisition of Medicis Pharmaceuticals Corp.

The company’s net loss widened to $27.5 million, or 9 cents per share, from $12.9 million, or 4 cents per share, a year earlier.

Cash earnings, or profit adjusted for one-time items, amounted to $1.30 per share.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below